Vanguard Capital Management
MBOT icon

Vanguard Capital Management’s Microbot Medical MBOT Stock Holding History

Vanguard Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67M Sell
2,906,810
-2,715
-0.1% -$5.54K ﹤0.01% 3074
2026
Q1 		$7.01M Buy
+2,909,525
New +$6.5M ﹤0.01% 2921

Other funds holding MBOT

Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management's MBOT Position: Q2 2026 in Review

Vanguard Capital Management reduced its Microbot Medical (MBOT) stake by 0.09% in Q2 2026, selling an estimated $5.54K and leaving 2,906,810 shares worth $5.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3074.

Vanguard Capital Management first reported a position in MBOT in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.01M in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Vanguard Capital Management held 2,906,810 shares of Microbot Medical worth $5.67M as of Q2 2026.
  • Vanguard Capital Management sold 2,715 Microbot Medical shares in Q2 2026, an estimated $5.54K.
  • Microbot Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3074 holding.
  • Vanguard Capital Management first reported a position in Microbot Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Microbot Medical position peaked at $7.01M in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.